Skip to content

The association analysis of circulating S100A8/9 with adverse events after clinical liver ischemia reperfusion

The association analysis of circulating S100A8/9 with adverse events after clinical liver ischemia reperfusion

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400094882
Enrollment
Unknown
Registered
2024-12-30
Start date
2025-01-01
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pediatric and adult liver transplantation, adult partial hepatectomy

Interventions

partial hepatectomy group:None
Adult liver transplantation group:None
Pediatric liver transplantation group:None

Sponsors

Tianjin First Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Patients who are scheduled for liver transplantation or hepatectomy; 2.No gender limitation; 3.The age of pediatric liver transplantation patients was 5 to 24 months, and The age of adult liver transplantation and adult partial liver resection patients was >18 years old; 4.ASA grade I to III; 5.Cardiac function grade I to II;

Exclusion criteria

Exclusion criteria: 1.Retransplantation; 2.Preoperative complication of heart, brain, lung and renal failure; 3.Preoperative complication was congenital heart disease; 4.Preoperative complication was congenital encephalopathy.

Design outcomes

Primary

MeasureTime frame
S100A8/9;Perioperative adverse events of heart, brain, lung, kidney, intestine and other distal organs;

Countries

China

Contacts

Public ContactSheng Mingwei

Tianjin First Central Hospital

shengmingwei999@sina.com+86 22 23627318

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026